Stock listing
A2DQ2B Stock Price, News, Filings & Events — Savara, Inc.
Selected listing: A2DQ2B · LS · EUR · DE
This page tracks Savara, Inc.'s A2DQ2B:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DQ2B:LS. A2DQ2B:LS is the stock-level entry point for investors researching Savara, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2DQ2B:LS
- Asset type
- Stock
- Market cap
- $1.10B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Savara, Inc. A2DQ2B:LS stock context
This page tracks Savara, Inc.'s A2DQ2B:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DQ2B:LS. A2DQ2B:LS is the stock-level entry point for investors researching Savara, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Savara, Inc.
Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Au...
August 24, 2026
Savara Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protecti...
July 30, 2026
Savara Announces Chief Financial and Administrative Officer Transition
June 8, 2026
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Research Savara, Inc.
Savara, Inc. investor report
Review AI stock analysis and investor report context for A2DQ2B:LS.
Savara, Inc. company profile
View the public company page for Savara, Inc. on 6ix.
Savara, Inc. news
Read company news and market updates connected to Savara, Inc..
Savara, Inc. investor events
Find investor webinars, events, and replay context for Savara, Inc..
Alternate listings
SVRA:NASDAQ
US · USD
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
A2DQ2B:LSX
DE · EUR
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
YB4P:GETTEX
DE · EUR
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
YB4P:FWB
DE · EUR
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
SVRA:BOATS
US · USD
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
YB4P:TRADEGATE
DE · EUR
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
YB4P:DUS
DE · EUR
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
YB4P:MUN
DE · EUR
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.
YB4P:SWB
DE · EUR
Alternate listing for Savara, Inc.; the primary context on this page is A2DQ2B:LS.